Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Scranton
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Scranton, PA

Studies commonly pay $75 to $4,500 per completed study

91 clinical trials are currently recruiting participants within 30 miles of Scranton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

91studies recruiting
5+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Scranton right now

Top 25 of 91 recruiting studies, sorted by proximity — each links to its official registry page

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 335 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05554406)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 320 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06686771)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma N/A Observational 800 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: University of Rochester
See eligibility & contact on ClinicalTrials.gov (NCT06073431)

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Solid Tumor Phase 1 Interventional 410 participants sought
Mary Crowley Medical Research Center — Dallas, Pennsylvania (16.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06619587)

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 2,130 participants sought
Research Site — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07431281)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Left vs Left Randomized Clinical Trial

Heart Failure, Heart Failure With Reduced Ejection Fraction N/A Interventional 2,136 participants sought
Geisinger Commonwealth School of Medicine — Scranton, Pennsylvania (0.3 mi) · Sponsor: Baylor College of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT05650658)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 147 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06317649)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Northeast Radiation Oncology Center — Dunmore, Pennsylvania (2.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06500455)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06992427)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Core Binding Factor Acute Myeloid Leukemia Phase 2 Interventional 162 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06917911)

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: PrECOG, LLC.
See eligibility & contact on ClinicalTrials.gov (NCT06538038)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Cancer N/A Interventional 500 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Eastern Cooperative Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06756607)

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

AL Amyloidosis Phase 3 Interventional 338 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06022939)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Lung Non-Small Cell Carcinoma Phase 2 Interventional 88 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06116682)
Actively enrolling

Studies you may be able to join near Scranton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Scranton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Northeast Clinical Trials Group (NECTR)

★ 5.0
802 Jefferson Ave, Scranton, PA 18510
(570) 504-5507

Altasciences

★ 4.2
130 Discovery Dr, Scott, PA 18447
(800) 300-8114

Lehigh Center for Clinical Research

★ 5.0
1245 S Cedar Crest Blvd, Allentown, PA 18103
(610) 820-0342
"Staff was very friendly and explained information to me in great detail"
— Virgilio Baello, 5★

Velocity Clinical Research

★ 4.5
4100 Vestal Rd Ste LL-100, Vestal, NY 13850
(607) 794-5790
"I've been waiting a week for them to pay me and I bet they're not even going to compensate me for the inconvenience of their ignorance. My old lady 6…"
— Obee Mcspanky, 2★

Geisinger Precision Health Center

★ 5.0
190 Welles St, Forty Fort, PA 18704
(570) 714-6420

Clinical trials in Scranton: what's recruiting

The Scranton area currently has 91 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Scranton, the most active research areas are:

  • Cancer & Oncology22 studies
  • Heart & Vascular2 studies
  • Liver & Kidney1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Scranton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Scranton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Scranton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Scranton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Scranton, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Scranton?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Scranton typically complete one or two studies per year.

Paid clinical trials near Scranton

Other metros within reach

Binghamton, NY20 Allentown, PA228 Reading, PA271 Trenton, NJ2,339 Philadelphia, PA2,171 Lancaster, PA424 Paterson, NJ4,155 Newark, NJ4,276

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Scranton Bladder Issues Due To Spinal Cord Injury in Scranton All conditions

More of PA

Philadelphia2,171 Pittsburgh1,234 York443 Lancaster424 Harrisburg400 Reading271 Allentown228 Erie88

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts